TP53 and cancer: Originally developed for its antibacterial properties, taurolidine has few detrimental effects on normal cells [7] but inhibits cancer cell proliferation [8] and tumor growth by inducing apoptosis [5,9-12] possibly through p53-dependent mechanisms [13].